VBI Vaccines Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for VBI Vaccines.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 28.0% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook
Sep 22VBI Vaccines gets up to $100M debt funding from K2 HealthVentures
Sep 15Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe
Sep 08VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings
Aug 26VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis
Jun 17Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?
Jun 09
Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?
Jan 24In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as VBI Vaccines has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2024 | 9 | -84 | -51 | -51 | N/A |
| 12/31/2023 | 9 | -94 | -62 | -61 | N/A |
| 9/30/2023 | 8 | -115 | -70 | -68 | N/A |
| 6/30/2023 | 2 | -119 | -81 | -77 | N/A |
| 3/31/2023 | 1 | -120 | -80 | -75 | N/A |
| 12/31/2022 | 1 | -113 | -78 | -74 | N/A |
| 9/30/2022 | 1 | -111 | -77 | -73 | N/A |
| 6/30/2022 | 1 | -102 | -63 | -60 | N/A |
| 3/31/2022 | 0 | -73 | -55 | -53 | N/A |
| 12/31/2021 | 1 | -70 | -42 | -40 | N/A |
| 9/30/2021 | 1 | -66 | -40 | -38 | N/A |
| 6/30/2021 | 1 | -63 | -51 | -49 | N/A |
| 3/31/2021 | 1 | -56 | -47 | -46 | N/A |
| 12/31/2020 | 1 | -46 | -48 | -47 | N/A |
| 9/30/2020 | 1 | -42 | -40 | -39 | N/A |
| 6/30/2020 | 2 | -45 | -39 | -38 | N/A |
| 3/31/2020 | 2 | -49 | -44 | -42 | N/A |
| 12/31/2019 | 2 | -55 | -52 | -49 | N/A |
| 9/30/2019 | 4 | -63 | -54 | -48 | N/A |
| 6/30/2019 | 4 | -62 | -54 | -47 | N/A |
| 3/31/2019 | 4 | -66 | -58 | -51 | N/A |
| 12/31/2018 | 3 | -64 | -52 | -46 | N/A |
| 9/30/2018 | 1 | -56 | -51 | -47 | N/A |
| 6/30/2018 | 1 | -50 | -42 | -40 | N/A |
| 3/31/2018 | 1 | -43 | -33 | -32 | N/A |
| 12/31/2017 | 1 | -39 | N/A | -31 | N/A |
| 9/30/2017 | 1 | -36 | N/A | -30 | N/A |
| 6/30/2017 | 1 | -33 | N/A | -28 | N/A |
| 3/31/2017 | 1 | -31 | N/A | -25 | N/A |
| 12/31/2016 | 1 | -23 | N/A | -19 | N/A |
| 9/30/2016 | 0 | -19 | N/A | -14 | N/A |
| 6/30/2016 | 0 | -31 | N/A | -14 | N/A |
| 3/31/2016 | 1 | -25 | N/A | -9 | N/A |
| 12/31/2015 | 1 | -26 | N/A | -9 | N/A |
| 9/30/2015 | 2 | -23 | N/A | -8 | N/A |
| 6/30/2015 | 2 | -6 | N/A | -7 | N/A |
| 3/31/2015 | 2 | -6 | N/A | -5 | N/A |
| 12/31/2014 | 3 | -6 | N/A | -5 | N/A |
| 12/31/2013 | 2 | -9 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if VBIV.Q's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if VBIV.Q's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if VBIV.Q's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if VBIV.Q's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if VBIV.Q's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VBIV.Q's Return on Equity is forecast to be high in 3 years time